Glaxo Sues Israeli Drug Maker For Trademark Infringement

Law360, New York (February 9, 2004, 12:00 AM EST) -- GlaxoSmithKline is suing Israeli drug maker Dexxon in the Tel Aviv District Court, asking the court to bar the use of the name Zanidex for a generic version of its Zantac indigestion drug.

The U.K. drug maker is seeking a permanent injunction, an order to present accounts, and a mandatory injunction against generic drug manufacturers and marketers Dexxon and Dexal.

The complaint asserts that Dexxon and Dexal named their generic version Zanidex, closely resembling the name of the original drug, in an attempt to exploit the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.